Claire Coeshott

1.4k total citations
26 papers, 1.1k citations indexed

About

Claire Coeshott is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Claire Coeshott has authored 26 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Immunology, 11 papers in Oncology and 6 papers in Molecular Biology. Recurrent topics in Claire Coeshott's work include Immunotherapy and Immune Responses (10 papers), Cancer Research and Treatments (5 papers) and CAR-T cell therapy research (5 papers). Claire Coeshott is often cited by papers focused on Immunotherapy and Immune Responses (10 papers), Cancer Research and Treatments (5 papers) and CAR-T cell therapy research (5 papers). Claire Coeshott collaborates with scholars based in United States, Bulgaria and Singapore. Claire Coeshott's co-authors include John C. Cheronis, Maciej Wieczorek, Sherman Ross, Donald Bellgrau, David Apelian, S. Louise Smithson, M.A. Julie Westerink, Gary J. Rosenthal, Daniel R. Kuritzkes and Richard C. Duke and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Medicine and Journal of Clinical Oncology.

In The Last Decade

Claire Coeshott

25 papers receiving 1.1k citations

Peers

Countries citing papers authored by Claire Coeshott

Since Specialization

Citations

This map shows the geographic impact of Claire Coeshott's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Claire Coeshott with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Claire Coeshott more than expected).

Fields of papers citing papers by Claire Coeshott

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Claire Coeshott. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Claire Coeshott. The network helps show where Claire Coeshott may publish in the future.

Co-authorship network of co-authors of Claire Coeshott

This figure shows the co-authorship network connecting the top 25 collaborators of Claire Coeshott. A scholar is included among the top collaborators of Claire Coeshott based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Claire Coeshott. Claire Coeshott is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Ultrasound-Guided Injections of HYADD4 for Knee Osteoarthritis Improves Pain and Functional Outcomes at 3, 6, and 12 Months without Changes in Measured Synovial Fluid, Serum Collagen Biomarkers, or Most Synovial Fluid Biomarker Proteins at 3 Months 2023 ·Journal of Clinical Medicine ·Richard T. Meehan, (unknown), (unknown), Claire Coeshott, Manuel Galvan, (unknown), Isabelle Amigues, (unknown), Elizabeth A. Regan, James Crooks, Gregory J. Czuczman, Vijaya Knight	3
2	A Phase 2 Randomized Placebo-Controlled Adjuvant Trial of GI-4000, a Recombinant Yeast Expressing Mutated RAS Proteins in Patients with Resected Pancreas Cancer 2021 ·SHILAP Revista de lepidopterología ·Peter Muscarella, Tanios Bekaii‐Saab, Kristi McIntyre, Alexander S. Rosemurgy, Sharona Ross, Donald Richards, William E. Fisher, Patrick J. Flynn, (unknown), Claire Coeshott, Heinrich Röder, Joanna Roder, Frank E. Harrell, Allen Lee Cohn, Timothy C. Rodell, David Apelian, (unknown)	17
3	A Comparison of Automated Perfusion- and Manual Diffusion-Based Human Regulatory T Cell Expansion and Functionality Using a Soluble Activator Complex 2020 ·Cell Transplantation ·Mark Jones, (unknown), Kelly Cristine Santos Roballo, (unknown), Jared Bushman, Claire Coeshott	9
4	Large-scale expansion and characterization of CD3+ T-cells in the Quantum® Cell Expansion System 2019 ·Journal of Translational Medicine ·Claire Coeshott, (unknown), Mark Jones, (unknown)	30
5	Evaluation of reagents used to coat the hollow-fiber bioreactor membrane of the Quantum® Cell Expansion System for the culture of human mesenchymal stem cells 2018 ·Materials Science and Engineering C ·(unknown), Mark Jones, (unknown), Claire Coeshott	19
6	Optimizing T Cell Expansion in a Hollow-Fiber Bioreactor 2018 ·Current Stem Cell Reports ·(unknown), Mark Jones, (unknown), (unknown), Claire Coeshott, (unknown)	26
7	Whole Recombinant Saccharomyces cerevisiae Yeast Expressing Ras Mutations as Treatment for Patients With Solid Tumors Bearing Ras Mutations: Results From a Phase 1 Trial 2018 ·Journal of Immunotherapy ·Allen Lee Cohn, Michael A. Morse, Bert H. O’Neil, Samuel H. Whiting, Claire Coeshott, John A. Ferraro, Donald Bellgrau, David Apelian, Timothy C. Rodell	32
8	Phase II Study of the GI-4000 KRAS Vaccine After Curative Therapy in Patients With Stage I-III Lung Adenocarcinoma Harboring a KRAS G12C, G12D, or G12V Mutation 2014 ·Clinical Lung Cancer ·Jamie E. Chaft, Anya M. Litvak, Maria E. Arcila, (unknown), Sandra P. D’Angelo, Lee M. Krug, Valerie W. Rusch, (unknown), Claire Coeshott, Bernard J. Park, David Apelian, Mark G. Kris, Christopher G. Azzoli	64
9	Safety, tolerability and immunogenicity of GS-4774, a hepatitis B virus-specific therapeutic vaccine, in healthy subjects: A randomized study 2014 ·Vaccine ·Anuj Gaggar, Claire Coeshott, David Apelian, Timothy C. Rodell, (unknown), Gong Shen, G. Mani Subramanian, John G. McHutchison	80
10	A Whole Recombinant Yeast-Based Therapeutic Vaccine Elicits HBV X, S and Core Specific T Cells in Mice and Activates Human T Cells Recognizing Epitopes Linked to Viral Clearance 2014 ·PLoS ONE ·Thomas H. King, (unknown), Zhimin Guo, (unknown), Yingnian Lu, Claire Coeshott, Adam J. Gehring, Antonio Bertoletti, Zi Zong Ho, William E. Delaney, Anuj Gaggar, G. Mani Subramanian, John G. McHutchison, Shikha Shrivastava, Y.-J. Lee, Shyamasundaran Kottilil, Donald Bellgrau, Timothy C. Rodell, David Apelian	55
11	Abstract 5314: A proteomic signature predicts response to a therapeutic vaccine in pancreas cancer; analysis from the GI-4000-02 trial 2014 ·Cancer Research ·Donald Richards, Peter Muscarella, Tanios Bekaii‐Saab, Lalan S. Wilfong, Vic Velanovich, (unknown), Patrick J. Flynn, William E. Fisher, Samuel H. Whiting, (unknown), (unknown), Claire Coeshott, (unknown), Heinrich Röder, Joanna Roder, Allen Lee Cohn, Timothy C. Rodell	2
12	Abstract A28: Immune responses to mutated Ras - development of a yeast-based immunotherapeutic 2014 ·Molecular Cancer Research ·Claire Coeshott, (unknown), (unknown), (unknown), Zhimin Guo, Allen Lee Cohn, Timothy C. Rodell	7
13	A pilot trial of a combination of therapeutic vaccines (GI-4000 and GI-6207) as adjunctive therapy with first-line therapy with bevacizumab plus either FOLFOX or FOLFIRI in stage IV patients with newly diagnosed Ras-mutant positive or negative metastatic colorectal cancer. 2012 ·Journal of Clinical Oncology ·John L. Marshall, Jimmy J. Hwang, Michael J. Pishvaian, Aiwu Ruth He, Louis M. Weiner, (unknown), James L. Gulley, Christopher R. Heery, Jeffrey Schlom, (unknown), (unknown), John A. Ferraro, Claire Coeshott, Allen Lee Cohn, David Apelian, Timothy C. Rodell	2
14	Immunogenicity of GI-4000 vaccine in adjuvant consolidation therapy following definitive treatment in patients with stage I-III adenocarcinoma of the lung with G12C, G12D, or G12V KRAS mutations. 2011 ·Journal of Clinical Oncology ·Sandra P. D’Angelo, (unknown), Lee M. Krug, Corey J. Crevar, (unknown), (unknown), (unknown), Claire Coeshott, David Apelian, Allen Lee Cohn, Mark G. Kris, Christopher G. Azzoli	4
15	Pluronic® F127-based systemic vaccine delivery systems 2004 ·Vaccine ·Claire Coeshott, S. Louise Smithson, Evie L. Verderber, (unknown), (unknown), Gary J. Rosenthal, M.A. Julie Westerink	69
16	Whole recombinant yeast vaccine activates dendritic cells and elicits protective cell-mediated immunity 2001 ·Nature Medicine ·(unknown), (unknown), Claire Coeshott, (unknown), Daniel R. Kuritzkes, Donald Bellgrau, Alex Franzusoff, Richard C. Duke, Cara C. Wilson	181
17	Converting enzyme-independent release of tumor necrosis factor a and IL-1b from a stimulated human monocytic cell line in the presence of activated neutrophils or purified proteinase 3 (neutrophil elastaseycytokine processingyproteinase inhibitors) 1999 ·Claire Coeshott, (unknown), (unknown), Maciej Wieczorek, (unknown), (unknown), John C. Cheronis	46
18	656 Sulfamethoxazole-specific antibodies in patients with AIDS: a prospective study 1996 ·Journal of Allergy and Clinical Immunology ·Claire Coeshott, Charles H. Cook, (unknown), W. J. Burman, (unknown), (unknown), Charles E. McCall	4
19	Ia-specific mixed leukocyte reactive T cell hybridomas: analysis of their specificity by using purified class II MHC molecules in synthetic membrane system. 1986 ·The Journal of Immunology ·Claire Coeshott, Robert W. Chesnut, Ralph T. Kubo, Susan F. Grammer, (unknown), H M Grey	36
20	Production of antibodies to host IgG after transfer of histocompatible cells primed to host allotype. 1980 ·PubMed ·(unknown), C J Elson, Claire Coeshott	2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact